Chemical and biological education at Pivot Park
The lectureship drug discovery brought higher chemical and biological education back to Oss.
19 August 2022
Chemical and biological education at Pivot Park
The lectureship drug discovery brought higher chemical and biological education back to Oss.
Leaders in Life Sciences – #3 Willem Mulder
Willem Mulder is Hoogleraar Precisiegeneeskunde
Project Panther has reached it’s highest point
Both the Pivot Park and Heijmans flags have been raised and can now be seen waving in the wind on top of the Panther building.
Leaders in Life Sciences – #2 Carmen van Vilsteren
Carmen van Vilsteren is de Chair Topsector Life Sciences & Health en Director van e/MTIC.
Leaders in Life Sciences – #1 Clémence Ross
Clémence Ross is ambassadeur voor het Actieprogramma ‘Nieuwe kansen voor Topsector Life Sciences & Health’ (LSH) van het ministerie van Economische Zaken en Klimaat.
Open gesprekken met leiders in life sciences, Pivot Park initieert podcastserie
Op Pivot Park ontwikkelen ze veel meer dan geneesmiddelen. Met Leaders in Life Sciences draagt het Osse life sciences park vandaag bij aan de lancering van een podcastserie.
PPSC and CeMOS form a strategic partnership
PPSC and CeMOS have formed a strategic partnership to provide industry-leading joint early drug discovery services, with an emphasis on label-free “cell-based” target-centric, phenotypic, and functional MALDI MS assays for ultra-High-Throughput Screening (uHTS), hit-to-lead biological profiling and in-vitro DMPK/ADME-T.
Summer school: Introduction to preclinical drug discovery
After the success of last year, Radboud University has selected life sciences campus, Pivot Park in Oss, as the backdrop of one of their summer school courses in July 2022. Radboud University teamed up with Pivot Park Screening Centre, and HAN University of Applied Science to organize the summer school course: Introduction to preclinical drug discovery.
Sustainability at Pivot Park – replacement paper coffee cups
In 2020, we developed a strategic vision (Pivot Park Sustainability Report 2021-2026) of the opportunities and ambitions we can and could have regarding sustainability going forward. One of the short-term contributions we wanted to make is to replace the paper coffee cups.
Tienjarig bestaan van Pivot Park en het nieuwe Grizzly gebouw
Pivot Park viert deze week het tienjarig bestaan. Maar het mooiste ‘cadeau’ wordt pas in september 2023 uitgepakt: het grote gebouw Grizzly. Welke vijf bedrijven trekken daar in? Een voorstelrondje.
Synaffix Inks Deal with MacroGenics to Enable Next Generation ADCs
Synaffix announced their second deal of 2022 with MacroGenics, Inc. with a potential deal value of up to $586 million, plus royalties on commercial sales. MacroGenics will combine its proprietary antibody and bispecific DART® technology with their linker-payload technologies to develop up to three next generation both monospecific and bispecific conjugates.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.
